These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 30107892

  • 41. Morning melatonin has limited benefit as a soporific for daytime sleep after night work.
    Smith MR, Lee C, Crowley SJ, Fogg LF, Eastman CI.
    Chronobiol Int; 2005; 22(5):873-88. PubMed ID: 16298773
    [Abstract] [Full Text] [Related]

  • 42. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L.
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [Abstract] [Full Text] [Related]

  • 43. The benefits of four weeks of melatonin treatment on circadian patterns in resistance-trained athletes.
    Leonardo-Mendonça RC, Martinez-Nicolas A, de Teresa Galván C, Ocaña-Wilhelmi J, Rusanova I, Guerra-Hernández E, Escames G, Acuña-Castroviejo D.
    Chronobiol Int; 2015 Dec; 32(8):1125-34. PubMed ID: 26361788
    [Abstract] [Full Text] [Related]

  • 44. The basic physiology and pathophysiology of melatonin.
    Claustrat B, Brun J, Chazot G.
    Sleep Med Rev; 2005 Feb; 9(1):11-24. PubMed ID: 15649735
    [Abstract] [Full Text] [Related]

  • 45. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL.
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [Abstract] [Full Text] [Related]

  • 46. [Pharmacotherapies for insomnia].
    Vecchierini MF, Léger D.
    Rev Prat; 2024 Mar; 74(3):297-302. PubMed ID: 38551874
    [Abstract] [Full Text] [Related]

  • 47. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ, Emens JS.
    Sleep Med Clin; 2020 Jun; 15(2):301-310. PubMed ID: 32386703
    [Abstract] [Full Text] [Related]

  • 48. Prolonged-release melatonin for the treatment of insomnia in patients over 55 years.
    Wade A, Downie S.
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1567-72. PubMed ID: 18808316
    [Abstract] [Full Text] [Related]

  • 49. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 50. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.
    Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA.
    Sleep; 2006 May; 29(5):609-18. PubMed ID: 16774150
    [Abstract] [Full Text] [Related]

  • 51. Melatonin agonists and insomnia.
    Ferguson SA, Rajaratnam SM, Dawson D.
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [Abstract] [Full Text] [Related]

  • 52. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
    Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM.
    Clin Interv Aging; 2023 Feb; 18():49-59. PubMed ID: 36660543
    [Abstract] [Full Text] [Related]

  • 53. Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.
    Dawson D, Rogers NL, van den Heuvel CJ, Kennaway DJ, Lushington K.
    J Biol Rhythms; 1998 Dec; 13(6):532-8. PubMed ID: 9850013
    [Abstract] [Full Text] [Related]

  • 54. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT.
    van Geijlswijk IM, van der Heijden KB, Egberts AC, Korzilius HP, Smits MG.
    Psychopharmacology (Berl); 2010 Oct; 212(3):379-91. PubMed ID: 20668840
    [Abstract] [Full Text] [Related]

  • 55. Association between light exposure at night and insomnia in the general elderly population: the HEIJO-KYO cohort.
    Obayashi K, Saeki K, Kurumatani N.
    Chronobiol Int; 2014 Nov; 31(9):976-82. PubMed ID: 25025617
    [Abstract] [Full Text] [Related]

  • 56. Human circadian rhythms: physiological and therapeutic relevance of light and melatonin.
    Skene DJ, Arendt J.
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):344-53. PubMed ID: 17022876
    [Abstract] [Full Text] [Related]

  • 57. Melatonin: from the hormone to the drug?
    Claustrat B, Brun J, Geoffriau M, Chazot G.
    Restor Neurol Neurosci; 1998 Jun; 12(2-3):151-7. PubMed ID: 12671310
    [Abstract] [Full Text] [Related]

  • 58. Guidelines for prescribing melatonin.
    Avery D, Lenz M, Landis C.
    Ann Med; 1998 Feb; 30(1):122-30. PubMed ID: 9556099
    [Abstract] [Full Text] [Related]

  • 59. [Melatonin: from hormone to drug?].
    Claustrat B, Geoffriau M, Brun J, Chazot G.
    Pathol Biol (Paris); 1996 Sep; 44(7):645-53. PubMed ID: 8977921
    [Abstract] [Full Text] [Related]

  • 60. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
    Srinivasan V, Zakaria R, Othaman Z, Brzezinski A, Prasad A, Brown GM.
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.